Yoichi Ohashi
Papers
1
Total Citations
12
H-Index
1
About
Yoichi Ohashi is a leading figure in the advancement of stereotactic body radiation therapy (SBRT), with a focused expertise in the clinical application of multileaf collimators (MLCs) for robotic radiosurgery systems. His most cited work, a 2017 study on the clinical usefulness of MLCs for prostate SBRT, has garnered 12 citations and represents a pivotal contribution to the field. In this research, Ohashi systematically demonstrated that MLCs offer significant advantages over traditional circular collimators in treating localized prostate cancer, providing superior dose conformity and treatment efficiency. His findings have directly influenced clinical protocols, helping to establish MLC-based SBRT as a preferred modality. By rigorously comparing these technologies, Ohashi has not only enhanced treatment precision but also improved patient outcomes, reducing toxicity while maintaining high tumor control rates. His work stands as a benchmark for integrating advanced collimation into robotic radiosurgery, underscoring his role as a key innovator in modern radiation oncology. For students and researchers, Ohashi’s contributions exemplify how targeted engineering and clinical validation can transform cancer therapy.
Research Focus
Key Achievements
Top Papers
- 1